Clinical aspects of neurocysticercosis in children

Pediatric Neurology

Volumn 22, Issue 4, 2000, Pages 287-291

  Morales, Nı́vea M O ^a   Agapejev, Svetlana ^a   Morales, Rogério R ^a   Padula, Niúra A M R ^a   Lima, Márcia M F ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTICONVULSIVE AGENT; DEXCHLORPHENIRAMINE; PRAZIQUANTEL;

ARTICLE; BEHAVIOR DISORDER; BRAZIL; CEREBROSPINAL FLUID EXAMINATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FEMALE; HEADACHE; HUMAN; IMAGING; INFANT; INTRACRANIAL HYPERTENSION; LABORATORY TEST; LEARNING DISORDER; MALE; NEUROCYSTICERCOSIS; NEUROLOGIC EXAMINATION; PALLIATIVE THERAPY; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; REMISSION; RETROSPECTIVE STUDY; SEIZURE; URBAN AREA;

ALBENDAZOLE; ANTHELMINTICS; ANTIPROTOZOAL AGENTS; BRAZIL; CHILD; CHILD, PRESCHOOL; EOSINOPHILS; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; LEUKOCYTE COUNT; MALE; NEUROCYSTICERCOSIS; PRAZIQUANTEL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URBAN POPULATION;

EID: 0034052176     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(99)00158-7     Document Type: Article

References (31)

1. Acha PN, Szyfres B. Zoonosis y enfermedades transmisibles comunes al hombre y a los animales, 2nd ed. Washington: OPS/OMS Publicación Scientifica 1986;503:763-74.
2. Singh G. Neurocysticercosis in South-Central America and the Indian subcontinent A comparative study. Arq Neuropsiquiatr. 5:1997;349-356.
3. Grill J., Pillet P., Rakotomalala W., et al. [Neurocysticercosis Pediatric aspects]. Arch Pediatr. 3:1996;360-368.
4. Rosenfeld E.A., Byrd S.E., Shulman S.T. Neurocysticercosis among children in Chicago. Clin Infect Dis. 23:1996;262-268.
5. Dixon H.B.F., Lipscomb F.M. Cysticercosis An analysis and follow up of 450 cases. Med Res Council Special Report Series. 299:1961;1-58.
6. Ruiz M., Astiazarán A.G. Neurocisticercosis pediátrica en México. San Estebán J.E., Flisser A., Astiazarán A.G. Neurocisticercosis en la infancia. 1997;7-18 Grupo Editorial Miguel Ángel Porruá México.
7. Del Brutto O.H. [Neurocysticercosis in children Clinical and radiological analysis and prognostic factors in 54 patients]. Rev Neurol. 25:1997;1681-1684.
8. Escobar A. Cerebral cysticercosis. N Engl J Med. 298:1987;403-404.
9. Lefèvre A.B., Diament A.J., Valente M.I. [Psychic disturbance in children with neurocysticercosis]. Arq Neuropsiquiatr (São Paulo). 27:1969;103-108.
10. Kalra V., Sethi M.B.B.S. Childhood neurocysticercosis - epidemiology, diagnosis and course. Acta Paediatr Jpn. 34:1992;365-370.
11. Manreza M.L.G. Neurocysticercosis in children - clinical and therapeutic aspects. Fejerman N., Chamoles N.A. New trends in pediatric neurology. 1993;295-298 Elsevier Science, Amsterdam.
12. Del Brutto O.H., Wadia N.H., Dumas M., Cruz M., Tsang V.C.W., Schantz P.M. Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci. 142:1996;1-6.
13. Mehta S.S., Hatfield S., Jessen L., Vogel D. Albendazole versus praziquantel for neurocysticercosis. Am J Health Syst Pharm. 55:1998;598-600.
14. Marriner S., Bogan J. Pharmacokinetics of albendazole in sheep. Am J Vet Res. 41:1980;1126-1129.
15. St. Geme J.W. III, Maldonado Y.A., Enzmann D., Hotez P.J., Overturf G., Schantz P.M. Consensus Diagnosis and management of neurocysticercosis in children. Pediatr Infect Dis J. 12:1993;455-461.
16. Cruz M., Cruz I., Horton J. Albendazole versus praziquantel in the treatment of cerebral cysticercosis Clinical evaluation. Trans Royal Soc Trop Med Hyg. 85:1991;244-247.
17. Quintero-Rodriguez E. Praziquantel vs. albendazole for cysticercosis. Neurosurgery. 23:1998;128.
18. Sotelo J., Escobedo F., Penagos P. Albendazole vs. praziquantel for therapy for neurocysticercosis A controlled trial. Arch Neurol. 45:1988;532-534.
19. White AC, Robinson P, Kuhn R. Taenia solium cysticercosis: Host-parasite interactions and the immune response. In: Freedman DO, ed. Immunopathogenetic aspects of disease induced by helminth parasites. Chem Immunol 1997;66:209-30.
20. Agapejev S., Meira D.A., Barraviera B., et al. Neurocysticercosis Treatment with albendazole and dextrochlorpheniramine. Trans Royal Soc Trop Med Hyg. 83:1989;377-383.
21. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia. 22:1981;489-501.
22. Manreza M.L.G. [Neurocysticercosis in childhood Clinical aspects and diagnosis]. Rev Hosp Clin Fac Med Sao Paulo. 37:1982;206-211.
23. Kramer L.D., Locke G.E., Byrd S.E., Daryabagi J. Cerebral cysticercosis Documentation of natural history with CT. Radiology. 171:1989;459-462.
24. Agapejev S. Epidemiology of neurocysticercosis in Brazil. Rev Inst Med Trop Sao Paulo. 38:1996;207-216.
25. Kalra V., Passi G.R. Cysticercosis the burden in India. San Estebán J.E., Flisser A., Astiazarán A.G. Neurocisticercosis en la infancia. 1997;67-74 Grupo Editorial Miguel Ángel Porruá México.
26. Biondi GF, Padilla A, Beltrán CJ, et al. Cisticercosis: Identificación de epitopes inmunogenicos del antígeno TCA 5.5 (abstract). Annals of the XIII Latin-American Congress of Parasitology, 1997:21.
27. Thussu A., Segal S., Sharma M., Lal V., Sawhney I.M.S., Prabhakar S. Comparison of cellular response in single- and multiple-lesion neurocysticercosis. Ann Trop Med Parasitol. 91:1997;627-632.
28. Pittella J.E.H. Neurocysticercosis. Brain Pathol. 7:1997;681-693.
29. Sheth T.N., Pilon L., Keystone J., Kucharczyk W. Persistent MR contrast enhancement of calcified neurocysticercosis lesions. Am J Neuroradiol. 19:1998;79-82.
30. Kalra V., Paul V.K., Marwah R.K., Kochhar G.S., Bhargava S. Neurocysticercosis in childhood. Trans Royal Soc Trop Med Hyg. 81:1987;371-373.
31. Ruiz-Garcia M., González-Astiazarán A., Rueda-Franco F. Neurocysticercosis in children Clinical experience in 122 patients. Childs Nerv Syst. 13:1997;608-612.